Expression of Concern
Vol. 95 No. 3 (2025)
https://doi.org/10.4081/monaldi.2024.3259
Editorial Expression of Concern: Lipid-lowering therapy in patients with coronary heart disease: an Italian real-life survey. Results from the Survey on Risk FactOrs and CardiovascuLar secondary prevention and drug strategieS (SOFOCLES) in Italy
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 12 November 2024
Published: 12 November 2024
Published: 12 November 2024
1623
Views
The Editors and the Publisher have been alerted to concerns about this article (DOI: 10.4081/monaldi.2024.2972 ), and an investigation is in progress. In the interim, we alert readers that these concerns have been raised.
This Expression of Concern will remain in place until the investigation is completed and any further needs for appropriate action have been taken.
Downloads
Download data is not yet available.
.
How to Cite
“Editorial Expression of Concern: Lipid-Lowering Therapy in Patients With Coronary Heart Disease: An Italian Real-Life Survey. Results from the Survey on Risk FactOrs and CardiovascuLar Secondary Prevention and Drug StrategieS (SOFOCLES) in Italy”. 2024. Monaldi Archives for Chest Disease 95 (3). https://doi.org/10.4081/monaldi.2024.3259.
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.